High-End Consumer Preference Towards Gonorrhea Therapeutics Likely to Boost Growth During 2019-2029
According to a new study of FactMR, the gonorrhea therapeutics market will reach ~US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain influenced by increased attention on new developments in novel therapeutic compounds or antimicrobials for improving the success potential of future treatment.
View full press release